Psoriasis under B-cell depleting therapies in multiple sclerosis: a retrospective multicenter analysis

Patricia Kirschner, Franz F. Konen, Franziska Axhausen, Ulas Ceylan, Erda Bucak, Romy Baumgart, Lars Masanneck, Stefan Gingele, Kerstin Steinbrink, Sven G. Meuth, Ralf Gold, Stephanie Wolff, Simon Faissner, Thomas Skripuletz, Steffen Pfeuffer, Marc Pawlitzki

Therapeutic Advances in Neurological Disorders

Published online on March 20, 2026

Abstract

Therapeutic Advances in Neurological Disorders, Volume 19, January-December 2026.
Background:B-cell depleting therapies (BCDT), including ocrelizumab, ofatumumab, and ublituximab, are highly effective disease-modifying therapies for multiple sclerosis (MS). Several case reports have raised concerns about new-onset or exacerbation of ...